RNS Number : 5035F
Dukemount Capital PLC
04 March 2024

4 March 2024

Dukemount Capital Plc

("Dukemount" or the "Company")

Capitalisation of Outstanding Loan, Issue of Equity and Warrants

The board of directors, Dukemount Capital Plc, is pleased to announce the capitalisation of the £900,000 ("Outstanding Balance"), due under the Facility Agreement dated 14 September 2021 (the "Facility Agreement") by way of an equity subscription at £0.001 per share (the "Subscription") into 900,000,000 new ordinary shares ("Subscription Shares") by Paul Gazzard, a director of Dukemount.

Background

The Outstanding Balance has been transferred and assigned to Paul Gazzard, a director of Dukemount. In consideration, the lenders of the Facility Agreement (the "Noteholders") will be paid £150,000 in cash and 225,000,000 new ordinary shares in Dukemount payable on completion of the Subscription.

Following admission to trading of the Subscription Shares, Mr Gazzard has agreed to sell the Subscription Shares at £0.001 to new investors for £150,000 ("New Investors"). These New Investors have agreed to transfer 225,000,000 of the total Subscription Shares to the Noteholders. The balance of 675,000,000 ordinary shares will be issued to the New Investors.

As the new investors were introduced by Peterhouse Capital Limited ("Peterhouse") and in light of the work undertaken by Peterhouse to date, the Company has agreed to provide Peterhouse with warrants over 3% of the Company's issued share capital from time to time, exercisable over 3 years at £0.001 (the "Warrants").

Completion of the Subscription is conditional on, inter alia :- the Subscription Shares being admitted to listing on the Official List (standard listing segment) and to trading on the London Stock Exchange's main market for listed securities on or around 5 March 2024.

Applications have be made to the FCA and the London Stock Exchange for admission in respect of the Subscription Shares. It is expected that Admission will become effective, and that dealings in the Subscription Shares are expected to commence, at 8.00 a.m. on 5 March 2024.

The rights attaching to the Subscription Shares will be uniform in all respects and all of the new Subscription Shares will rank pari passu and form a single class for all purposes with the existing issued shares of £0.001 par value in the Company.

Total Voting Rights

Following Admission, the Company has 969,316,623 ordinary shares of £0.001 par value in issue, each with one vote per share (and none of which are held in treasury). The total number of voting rights in the Company is therefore 969,316,623. This figure of 969,316,623 may be used by shareholders in the Company as the denominator for calculations to determine if they have a notifiable interest in the share capital of the Company under the Disclosure Guidance and Transparency Rules, or if such interest has changed. For further information, please visit www.dukemountcapitalplc.com or contact:

Dukemount Capital Plc : Email info@dukemountplc.com

CEO: Paul Gazzard

Non-Executive Director: Geoffery Dart

Broker Enquiries:

Peterhouse Capital Limited Tel: +44 (0) 207 469 0930

Lucy Williams/Duncan Vasey

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Gazzard

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dukemount Capital plc

b)

LEI

213800IVPZ932NP24O44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of £0.001 each

ISIN: GB00BMWC6Q55

b)

Nature of the transaction

Capitalisation of £900,000 into 900,000,000 new ordinary shares

c)

Price(s) and volume(s)

Price No. of shares

£0.001 900,000,000

d)

Aggregated information

- Aggregated volume

- Price

900,000,000

£0.001

e)

Date of the transaction

5 March 2024

f)

Place of the transaction

Outside a trading venue

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Paul Gazzard

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dukemount Capital plc

b)

LEI

213800IVPZ932NP24O44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of £0.001 each

ISIN: GB00BMWC6Q55

b)

Nature of the transaction

Disposal of 900,000,000 ordinary shares

c)

Price(s) and volume(s)

Price No. of shares

£0.001 900,000,000

d)

Aggregated information

- Aggregated volume

- Price

900,000,000

£0.001

e)

Date of the transaction

5 March 2024

f)

Place of the transaction

Outside a trading venue

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCMZGGFFDKGDZM